AVALO THERAPEUTICS, INC. Increase (Decrease) in Accounts Receivable
AVALO THERAPEUTICS, INC. (AVTX) reported Increase (Decrease) in Accounts Receivable of $0 for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2024-08-12
- AVALO THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2023-12-31 was $0.00.
- AVALO THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2023-09-30 was -$38.00K.
- AVALO THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2023-06-30 was $38.00K.
- AVALO THERAPEUTICS, INC. increase (decrease) in accounts receivable for the quarter ending 2023-03-31 was $0.00.
- AVALO THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2023 was $0.00.
- AVALO THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2022 was -$1.06M.
- AVALO THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2021 was -$1.12M, a 264.75% decline from fiscal 2020.
- AVALO THERAPEUTICS, INC. increase (decrease) in accounts receivable for fiscal 2020 was $678.00K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | $0.00 10-Q · filed 2024-08-12 | |||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$38.00K derived: sum of 2 quarters · filed 2024-03-29 | $0.00 derived: sum of 3 quarters · filed 2024-08-12 | $0.00 10-K · filed 2024-03-29 | ||||
| 2023-09-30 | -$38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2024-08-12 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-06-30 | $38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $38.00K 10-Q · filed 2024-08-12 | $38.00K derived: sum of 3 quarters · filed 2024-08-12 | -$506.00K derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 | $0.00 derived: sum of 2 quarters · filed 2024-03-29 | -$544.00K derived: sum of 3 quarters · filed 2024-03-29 | -$937.00K derived: sum of 4 quarters · filed 2024-03-29 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$544.00K derived: sum of 2 quarters · filed 2024-03-29 | -$937.00K derived: sum of 3 quarters · filed 2024-03-29 | -$1.06M 10-K · filed 2024-03-29 | ||||
| 2022-09-30 | -$544.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$937.00K derived: sum of 2 quarters · filed 2023-11-09 | -$1.06M 10-Q · filed 2023-11-09 | -$1.44M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | -$393.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$516.00K 10-Q · filed 2023-08-03 | -$891.00K derived: sum of 3 quarters · filed 2023-08-03 | -$3.58M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | -$123.00K 10-Q · filed 2023-05-04 | -$498.00K derived: sum of 2 quarters · filed 2023-05-04 | -$3.18M derived: sum of 3 quarters · filed 2023-05-04 | -$2.19M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | -$375.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$3.06M derived: sum of 2 quarters · filed 2023-03-29 | -$2.07M derived: sum of 3 quarters · filed 2023-03-29 | -$1.12M 10-K · filed 2023-03-29 | ||||
| 2021-09-30 | -$2.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$1.70M derived: sum of 2 quarters · filed 2022-11-07 | -$742.00K 10-Q · filed 2022-11-07 | -$236.00K derived: sum of 4 quarters · filed 2022-11-07 | ||||
| 2021-06-30 | $990.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.94M 10-Q · filed 2022-08-04 | $2.45M derived: sum of 3 quarters · filed 2022-08-04 | $2.09M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $953.00K 10-Q · filed 2022-05-05 | $1.46M derived: sum of 2 quarters · filed 2022-05-05 | $1.10M derived: sum of 3 quarters · filed 2022-05-05 | $935.00K derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $506.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | $146.00K derived: sum of 2 quarters · filed 2022-03-02 | -$18.00K derived: sum of 3 quarters · filed 2022-03-02 | $678.00K 10-K · filed 2022-03-02 | $678.10K 10-K · filed 2021-03-08 | |||
| 2020-09-30 | -$360.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$524.00K derived: sum of 2 quarters · filed 2021-11-09 | $172.00K 10-Q · filed 2021-11-09 | $171.90K 10-Q · filed 2020-11-09 | -$3.28M derived: sum of 4 quarters · filed 2021-11-09 | |||
| 2020-06-30 | -$164.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | $532.00K 10-Q · filed 2021-08-02 | $532.46K 10-Q · filed 2020-08-06 | -$2.92M derived: sum of 3 quarters · filed 2021-08-02 | -$829.07K derived: sum of 4 quarters · filed 2021-08-02 | |||
| 2020-03-31 | $696.00K 10-Q · filed 2021-05-13 | $695.76K 10-Q · filed 2020-05-07 | -$2.76M derived: sum of 2 quarters · filed 2021-05-13 | -$665.07K derived: sum of 3 quarters · filed 2021-05-13 | -$523.17K derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | -$3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | -$1.36M derived: sum of 2 quarters · filed 2021-03-08 | -$1.22M derived: sum of 3 quarters · filed 2021-03-08 | -$1.66M 10-K · filed 2021-03-08 | ||||
| 2019-09-30 | $2.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $2.24M derived: sum of 2 quarters · filed 2020-11-09 | $1.80M 10-Q · filed 2020-11-09 | $1.95M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | $141.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$297.27K 10-Q · filed 2020-08-06 | -$148.25K derived: sum of 3 quarters · filed 2020-08-06 | -$448.04K derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | -$439.16K 10-Q · filed 2020-05-07 | -$290.14K derived: sum of 2 quarters · filed 2020-05-07 | -$589.93K derived: sum of 3 quarters · filed 2020-05-07 | -$111.96K derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $149.02K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | -$150.77K derived: sum of 2 quarters · filed 2020-03-11 | $327.20K derived: sum of 3 quarters · filed 2020-03-11 | $222.53K 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | -$299.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $178.18K derived: sum of 2 quarters · filed 2019-11-14 | $73.51K 10-Q · filed 2019-11-14 | $320.71K derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $477.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $373.30K 10-Q · filed 2019-08-08 | $620.49K derived: sum of 3 quarters · filed 2019-08-08 | $620.49K derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | -$104.67K 10-Q · filed 2019-05-09 | $142.52K derived: sum of 2 quarters · filed 2019-05-09 | $142.52K derived: sum of 3 quarters · filed 2019-05-09 | $142.52K derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $247.19K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $247.19K derived: sum of 2 quarters · filed 2019-03-18 | $247.19K derived: sum of 3 quarters · filed 2019-03-18 | $247.19K 10-K · filed 2019-03-18 | ||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $0.00 derived: sum of 2 quarters · filed 2018-11-13 | $0.00 10-Q · filed 2018-11-13 | |||||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 | ||||||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-11 | |||||||
| 2016-12-31 | $132.47K 10-K · filed 2018-04-02 | |||||||
| 2015-12-31 | $0.00 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |